Alejandro D. Ricart
- Oncology top 1%
- Molecular Biology top 5%
- Pathology and Forensic Medicine top 1%
- Immunology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Arun BalakumaranMargaret A. ShippCraig H. MoskowitzPier Luigi ZinzaniPhilippe ArmandAnthony W. TolcherSinil KimJean‐Marie Michot
- Topics
- Lymphoma Diagnosis and Treatment (15 papers)Colorectal Cancer Treatments and Studies (12 papers)Chronic Lymphocytic Leukemia Research (9 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Alejandro D. Ricart
56 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 2.5k
- Molecular Biology 1.4k
- Pathology and Forensic Medicine 1.0k
- Immunology 780
- Pulmonary and Respiratory Medicine 762
Countries citing papers authored by Alejandro D. Ricart
This map shows the geographic impact of Alejandro D. Ricart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro D. Ricart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro D. Ricart more than expected).
Fields of papers citing papers by Alejandro D. Ricart
This network shows the impact of papers produced by Alejandro D. Ricart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro D. Ricart. The network helps show where Alejandro D. Ricart may publish in the future.
Co-authorship network of co-authors of Alejandro D. Ricart
This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro D. Ricart. A scholar is included among the top collaborators of Alejandro D. Ricart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro D. Ricart. Alejandro D. Ricart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | TG-1701 A selective bruton tyrosine kinase (btk) inhibitor, as monotherapy and in combination with ublituximab and umbralisib (u2) in chronic lymphocytic leukemia (cll) and lymphoma | 1 |
| 2 | Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphomabreakdown → | 694 |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 6 | |
| 6 | 411 | |
| 7 | 56 | |
| 8 | 36 | |
| 9 | 27 | |
| 10 | 15 | |
| 11 | 35 | |
| 12 | 227 | |
| 13 | 204 | |
| 14 | 130 | |
| 15 | A phase I and pharmacokinetic study of a CanAg-targeted immunoconjugate, HuC242-DM4, in patients with CanAg-expressing solid tumors | 2 |
| 16 | Pharmacokinetic findings from the phase I study of Quarfloxin (CX-3543): a protein-rDNA quadruplex inhibitor, in patients with advanced solid tumors. | 10 |
| 17 | Clinical aspects of a phase I study of PD-0325901, a selective oral MEK inhibitor, in patients with advanced cancer | 13 |
| 18 | 67 | |
| 19 | Phase I trial of glycolitic inhibition with 2-deoxyglucose and docetaxel for patients with solid tumors | 4 |
| 20 | Phase I study of BMS-247550, an epothilone B analog, administered weekly for 3 weeks followed by a one-week break in patients (pts) with advanced malignancies | 3 |
About Alejandro D. Ricart
Alejandro D. Ricart is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics, having authored 57 papers that have together received 4.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (15 papers), Colorectal Cancer Treatments and Studies (12 papers) and Chronic Lymphocytic Leukemia Research (9 papers). The work is most often cited by research in Oncology (2.5k citations), Pathology and Forensic Medicine (1.0k citations) and Cancer Research (703 citations). Alejandro D. Ricart has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Arun Balakumaran, Margaret A. Shipp, Craig H. Moskowitz, Pier Luigi Zinzani, Philippe Armand, Anthony W. Tolcher, Sinil Kim, Jean‐Marie Michot, Vincent Ribrag and Ellen Snyder. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.